New England Journal of Medicine · 1983 · 251 citations · 47 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAnxiolytic PharmacologyAnxiolytic PharmacotherapyAnxiolytic TherapyAnxiolytic Use DisordersSedative PharmacologyBenzodiazepine Treatment
When the pharmacologic and clinical properties of the benzodiazepine sedative–anxioly tics were last reviewed comprehensively in 1973 and 1974,1 2 3 their use in clinical practice was very extensive and increasing.4 5 6 It was pointed out that a continuation of the yearly rate of increase would lead to the total tranquilization of America by the turn of the century.7 During the mid-1970s, however, concern emerged among both prescribers and users of these medications about this continuously increasing use. Articles in scientific publications and the lay press suggested some apparently dramatic consequences and hazards of tranquilizer use.8 9 10 11 12 Although the validity of most such reports . . .
47
Benzodiazepine Receptor: Demonstration in the Central Nervous System
H Möhler, Toshikazu Okada · Science · 1977 · 1.7K citations
Medicine, Neuroscience, Pharmacology +11
Benzodiazepine receptors in rat brain
Richard F. Squires · Nature · 1977 · 1.5K citations
Medicine, Neuroscience, Pharmacology +10
Selective antagonists of benzodiazepines
Walter Hunkeler, H. Möhler, L. Pieri et al. · Nature · 1981 · 1.2K citations
National Patterns of Psychotherapeutic Drug Use
Hugh J. Parry · Archives of General Psychiatry · 1973 · 332 citations